Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group"'
Autor:
Keiko Osugi, Yoshiki Kusunoki, Mana Ohigashi, Kenji Kusunoki, Chikako Inoue, Maki Inoue, Ayako Takagi, Taku Tsunoda, Manabu Kadoya, Kosuke Konishi, Tomoyuki Katsuno, Hidenori Koyama, Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 5, Pp 659-668 (2023)
ABSTRACT Aims Low‐carbohydrate diets have become popular in the general community. The mutual relationship between the percentage of total energy intake from carbohydrates (CHO/E), glycemic control indices, and diabetes complications remains unclea
Externí odkaz:
https://doaj.org/article/806652f002f54ef6b9918efdae550095
Autor:
Norihiro Kuroda, Yoshiki Kusunoki, Keiko Osugi, Mana Ohigashi, Daisuke Azuma, Hiroki Ikeda, Shinya Makino, Akihito Otsuka, Daisuke Tamada, Nobuaki Watanabe, Kahori Washio, Taku Tsunoda, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno, Hidenori Koyama, Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 244-253 (2021)
Abstract Aims/Introduction Continuous glucose monitoring (CGM) metrics, such as times in range (TIR) and time below range, have been shown to be useful as clinical targets that complement glycated hemoglobin (HbA1c) for patients with type 2 diabetes
Externí odkaz:
https://doaj.org/article/ec1fc5e5d6c54053936b11fca962944d
Autor:
Norihiro Kuroda, Yoshiki Kusunoki, Keiko Osugi, Mana Ohigashi, Daisuke Azuma, Hiroki Ikeda, Shinya Makino, Akihito Otsuka, Daisuke Tamada, Nobuaki Watanabe, Kahori Washio, Taku Tsunoda, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno, Hidenori Koyama, Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 244-253 (2021)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Continuous glucose monitoring (CGM) metrics, such as times in range (TIR) and time below range, have been shown to be useful as clinical targets that complement glycated hemoglobin (HbA1c) for patients with type 2 diabetes mellitus.